Dicot Pharma AB (FRA:KN0) OCF Yield %: -11.09 (As of Jul. 05, 2026)


FRA:KN0 Dicot Pharma AB FRA:KN0
23 GF Score
Price €0.01
! 2 Warning Signs
View Full Analysis

What is Dicot Pharma AB OCF Yield %?

Dicot Pharma AB FRA:KN0 -2.21% 23 OCF Yield % is -11.09 as of Jul. 05, 2026. GuruFocus rates FRA:KN0 with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Dicot Pharma AB ranks worse than 88.26% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Dicot Pharma AB's Trailing 12-Month Cash Flow from Operations is €-7.17 Mil, and Market Cap is €63.74 Mil. Therefore, Dicot Pharma AB's OCF Yield % for today is -11.09%.

The historical rank and industry rank for Dicot Pharma AB's OCF Yield % or its related term are showing as below:

FRA:KN0' s OCF Yield % Range Over the Past 10 Years
Min: -307.07   Med: -81.24   Max: -11.09
Current: -11.09


During the past 9 years, the highest OCF Yield % of Dicot Pharma AB was -11.09%. The lowest was -307.07%. And the median was -81.24%.

FRA:KN0's OCF Yield % is ranked worse than
88.26% of 1005 companies
in the Drug Manufacturers industry
Industry Median: 3.39 vs FRA:KN0: -11.09

Dicot Pharma AB's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Dicot Pharma AB OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Dicot Pharma AB OCF Yield % Related Terms


Dicot Pharma AB OCF Yield % Historical Data

* Premium members only.

The historical data trend for Dicot Pharma AB's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dicot Pharma AB OCF Yield % Chart

Dicot Pharma AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -19.94 -19.38 -10.85

Dicot Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.78 -9.96 -3.43 -10.34 -5.02

FRA:KN0 vs ZTS, UTHR: OCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dicot Pharma AB's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dicot Pharma AB OCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dicot Pharma AB's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Dicot Pharma AB's OCF Yield % falls into.


FRA:KN0
23GF Score
Dicot Pharma AB FRA:KN0
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dicot Pharma AB OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Dicot Pharma AB's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-7.889 / 72.737435102
=-10.85%

Dicot Pharma AB's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-1.188 * 4 / 94.732596602
=-5.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -11.09 mean?
Dicot Pharma AB (FRA:KN0) has a OCF Yield % of -11.09 as of Jul. 05, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Dicot Pharma AB and its competitors. According to the industry distribution chart, Dicot Pharma AB ranks #887 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 88.3%.
Is Dicot Pharma AB's OCF Yield % too high?
Dicot Pharma AB's current OCF Yield % is -11.09. Based on the distribution chart, Dicot Pharma AB ranks #887 out of 1005 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Dicot Pharma AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Dicot Pharma AB's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Dicot Pharma AB ranks #887 out of 1005 companies for OCF Yield %. This places Dicot Pharma AB in the lower half of its industry. The industry median OCF Yield % is 3.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.39, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Dicot Pharma AB and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dicot Pharma AB's current OCF Yield % is -11.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dicot Pharma AB stock overvalued right now?
Dicot Pharma AB (FRA:KN0) has a current OCF Yield % of -11.09. The current OCF Yield % is -11.09. Dicot Pharma AB's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Dicot Pharma AB (FRA:KN0), the current OCF Yield % is -11.09 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dicot Pharma AB Business Description

Other Exchanges DICOT:SwedenKN0:Germany
Address S:t Olofsgatan 11A, Uppsala, SWE, SE 753 21
Dicot Pharma AB is developing a modern potency medicine that will treat erectile dysfunction and premature ejaculation than existing preparations. The business model involves evaluating industrial and financial partnerships during clinical development to bring LIB-01 to commercialization on the world market. The company's drug candidate LIB-01 has a longer duration of action and fewer side effects, and is also used in the treatment of erectile dysfunction and premature ejaculation.
23GF Score

Get the complete analysis for FRA:KN0

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price